ArticleBMC infectious diseases2018

Cost-effectiveness of increasing vaccination in high-risk adults aged 18-64 Years: a model-based decision analysis.

Angela R Wateska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.